Merck, through a subsidiary, will acquire Verona Pharma for a total transaction value of approximately $10 billion.

Jefferies initiated coverage on British American Tobacco (NYSE:BTI) on Wednesday with a Buy rating and named the stock its top pick in the tobacco sector. The steadily improving profitability in ...

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...

A company expected to fare well during this time is Eli Lilly, with revenue forecast to improve by 165% in 2030. This will largely be driven by the company’s glucagon like peptide-1 receptor agonist ...

The $8 billion deal, which remains stuck in regulatory limbo, is poised to trigger its second 90-day extension next week.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its second-quarter 2025 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET ...

In a European study, higher consumption of fruits, vegetables, legumes, and potatoes was associated with a reduced risk of ...

Discover why MSD may face challenges as a hedge against a weaker dollar. Explore its premium valuation, low spreads, and potential downside.

Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention ...

The National Safety Council announced last week that its MSD Solutions Pilot Grant programs have shown practical applications and measurable progress toward reducing musculoskeletal disorders (MSDs), ...